Karen Lowe
Finanzdirektor/CFO bei Oxford Cannabinoid Technologies Ltd.
Vermögen: 1 533 $ am 30.04.2024
Profil
Karen Lowe is currently the Director-Finance & Director at Oxford Cannabinoid Technologies Ltd.
and a Member at the Association of Certified Fraud Examiners.
She previously worked as a Non-Executive Director at Oxford Cannabinoid Technologies Holdings Plc in 2022.
Ms. Lowe completed her undergraduate degree at Leeds Beckett University and Bremen University of Applied Sciences.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.04.2023 | 340 010 ( 0,03% ) | 1 533 $ | 30.04.2024 |
Aktive Positionen von Karen Lowe
| Unternehmen | Position | Beginn |
|---|---|---|
Association of Certified Fraud Examiners
 Association of Certified Fraud Examiners Miscellaneous Commercial ServicesCommercial Services The Association of Certified Fraud Examiners is a global organization that aims to reduce fraud worldwide by empowering anti-fraud professionals with leading-edge training, resources, and professional certification. The organization is based in Austin, TX. The organization offers membership, certification, and recertification programs, as well as fraud resources such as a fraud library, case studies, and a blog. | Corporate Officer/Principal | - |
Oxford Cannabinoid Technologies Ltd.
 Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Karen Lowe
| Unternehmen | Position | Ende |
|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Finanzdirektor/CFO | 26.08.2022 |
Ausbildung von Karen Lowe
| Leeds Beckett University | Undergraduate Degree |
| Bremen University of Applied Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Association of Certified Fraud Examiners
Association of Certified Fraud Examiners Miscellaneous Commercial ServicesCommercial Services The Association of Certified Fraud Examiners is a global organization that aims to reduce fraud worldwide by empowering anti-fraud professionals with leading-edge training, resources, and professional certification. The organization is based in Austin, TX. The organization offers membership, certification, and recertification programs, as well as fraud resources such as a fraud library, case studies, and a blog. | Commercial Services |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Health Technology |
